On November 1, 2019 Haemonetics Corporation (NYSE: HAE) reported that financial results for its second quarter and first half of fiscal 2020, which ended Sept. 28, 2019, are available on its Investor Relations website (Press release, Haemonetics, NOV 1, 2019, View Source [SID1234550192]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The Company is posting the earnings release and results tables that will be referenced on its webcast to its Investor Relations website.
Direct link to Earnings Release 2Q FY20:
Direct link to Results Tables 2Q FY20 That Will Be Referenced on Webcast:
The Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8 a.m. ET on Nov. 1, 2019. The call can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 9166003
A live webcast of the call can be accessed on Haemonetics’ investor relations website.
Direct link to Conference Call Webcast: View Source